MX360429B - Leptospira con masa antigenica incrementada. - Google Patents

Leptospira con masa antigenica incrementada.

Info

Publication number
MX360429B
MX360429B MX2015008059A MX2015008059A MX360429B MX 360429 B MX360429 B MX 360429B MX 2015008059 A MX2015008059 A MX 2015008059A MX 2015008059 A MX2015008059 A MX 2015008059A MX 360429 B MX360429 B MX 360429B
Authority
MX
Mexico
Prior art keywords
leptospira
antigenic mass
production
fatty acid
increased antigenic
Prior art date
Application number
MX2015008059A
Other languages
English (en)
Other versions
MX2015008059A (es
Inventor
Christian Theodoor Gerardus Smits
Edwin Kets
Henriette Adriaanse
Original Assignee
Intervet Int Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Intervet Int Bv filed Critical Intervet Int Bv
Publication of MX2015008059A publication Critical patent/MX2015008059A/es
Publication of MX360429B publication Critical patent/MX360429B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/0208—Specific bacteria not otherwise provided for
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/0225—Spirochetes, e.g. Treponema, Leptospira, Borrelia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/38—Chemical stimulation of growth or activity by addition of chemical compounds which are not essential growth factors; Stimulation of growth by removal of a chemical compound
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/521—Bacterial cells; Fungal cells; Protozoal cells inactivated (killed)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Virology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

La presente invención se refiere a masa antigénica de cultivos de Leptospira puede ser incrementada significativamente, independiente de cualquier incremento en biomasa, al suplementar cultivos de Leptospira con un tipo específico de ácido graso: un ácido graso poliinsaturado C18; esto provee ventajas en la producción de antígenos de Leptospira; también, esto permite la producción de vacunas contra Leptospirosis mejoradas, que son más seguras y más efectivas.
MX2015008059A 2012-12-21 2013-12-20 Leptospira con masa antigenica incrementada. MX360429B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP12199264 2012-12-21
PCT/EP2013/077590 WO2014096311A1 (en) 2012-12-21 2013-12-20 Leptospira with increased antigenic mass

Publications (2)

Publication Number Publication Date
MX2015008059A MX2015008059A (es) 2015-10-30
MX360429B true MX360429B (es) 2018-10-31

Family

ID=47458759

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2015008059A MX360429B (es) 2012-12-21 2013-12-20 Leptospira con masa antigenica incrementada.

Country Status (14)

Country Link
US (2) US20140178433A1 (es)
EP (1) EP2935565B1 (es)
JP (2) JP6212569B2 (es)
CN (1) CN104854234B (es)
AU (1) AU2013366583B2 (es)
BR (1) BR112015014343B1 (es)
CA (1) CA2893096C (es)
ES (1) ES2735601T3 (es)
HU (1) HUE045329T2 (es)
MX (1) MX360429B (es)
NZ (1) NZ708578A (es)
RU (1) RU2679040C2 (es)
WO (1) WO2014096311A1 (es)
ZA (1) ZA201504231B (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20140178433A1 (en) * 2012-12-21 2014-06-26 Edwin Kets Leptospira with increased antigenic mass
WO2022187784A1 (en) * 2021-03-04 2022-09-09 Kansas State University Research Foundation Methods for increasing weight gain in pigs

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU1538305A1 (ru) * 1987-07-21 1994-12-15 Всесоюзный государственный научно-контрольный институт ветеринарных препаратов Госагропрома СССР Ассоциированная вакцина против лептоспироза и парвовирусной инфекции свиней
EP1879998B1 (en) * 2005-04-20 2009-12-16 Merial Ltd. Leptospirosis culture process
US20140178433A1 (en) * 2012-12-21 2014-06-26 Edwin Kets Leptospira with increased antigenic mass

Also Published As

Publication number Publication date
CA2893096C (en) 2022-04-05
BR112015014343A2 (pt) 2020-01-28
WO2014096311A1 (en) 2014-06-26
US20140178433A1 (en) 2014-06-26
RU2679040C2 (ru) 2019-02-05
BR112015014343B1 (pt) 2022-03-29
EP2935565A1 (en) 2015-10-28
US20150306199A1 (en) 2015-10-29
AU2013366583B2 (en) 2019-07-18
ZA201504231B (en) 2016-04-28
RU2015129719A (ru) 2017-01-30
JP6212569B2 (ja) 2017-10-11
EP2935565B1 (en) 2019-06-05
JP2016504028A (ja) 2016-02-12
CN104854234B (zh) 2018-02-02
HUE045329T2 (hu) 2019-12-30
CN104854234A (zh) 2015-08-19
CA2893096A1 (en) 2014-06-26
JP2017200935A (ja) 2017-11-09
AU2013366583A1 (en) 2015-06-11
NZ708578A (en) 2019-07-26
US10046038B2 (en) 2018-08-14
ES2735601T3 (es) 2019-12-19
MX2015008059A (es) 2015-10-30

Similar Documents

Publication Publication Date Title
PH12014502795A1 (en) Production of long chain polyunsaturated fatty acids in plant cells
EA201890942A1 (ru) Мультивалентные вакцины с синтетическими наноносителями
MY165893A (en) Biological methods for preparing a fatty dicarboxylic acid
NZ705606A (en) Methods for identifying antibodies with reduced immunogenicity
IN2015DN00924A (es)
MX366179B (es) Variantes de enzima con propiedades de ester sintasa mejoradas.
IN2015DN03281A (es)
AU344619S (en) Bottle
AU348270S (en) Bottle
NZ715459A (en) A hyperbarically-inactivated microorganism, immunogenic compositions comprising same and methods for producing same
PL3078737T3 (pl) Mikroorganizm Corynebacterium o ulepszonej zdolności do wytwarzania L-lizyny i sposób wytwarzania L-lizyny przy użyciu tegoż
NZ708442A (en) Process for manufacturing biofuels
IN2014MN01621A (es)
PT2733197E (pt) Central geradora de biogás com câmara de fermentação em forma de túnel, e instalações para produzir e utilizar biogás
MX2015008059A (es) Leptospira con masa antigenica incrementada.
IN2014DN02050A (es)
AR090964A1 (es) Proceso para la elaboracion de undecapeptidos ciclicos
TH173460A (th) เลปโตสไปร่าที่มีมวลสารก่อภูมิคุ้มกันที่ถูกเพิ่มขึ้น (Leptospira with increased Antigenic Mass)
HK1220606A1 (zh) 包含非可氧化脂肪酸的天然脂类
WO2013182715A8 (es) Procedmiento de producción de biocombustibles y co-productos alimentarios empleando extractos de cultivo de microalgas
UA77647U (ru) Способ получения противоопухолевой вакцины
AU335314S (en) An upper for footwear
AU335512S (en) An upper for footwear
AU335315S (en) An upper for footwear
AU341776S (en) An upper for footwear

Legal Events

Date Code Title Description
FG Grant or registration